explore -WSS

explore

author：comprehensive 2025-09-10 05:03:22 - browse：1426

After a drawn-out lobbying fight, ARPA-H chose its headquarters: a hub and spokes model, with three central locations in Boston, Texas, and D.C. David L. Ryan/Boston Globe

WASHINGTON — Cities and states have been clamoring to play host to the Advanced Research Projects Agency for Health since before the agency existed — before, in fact, anyone truly knew what ARPA-H was.

But the lobbying campaign from universities, business leaders, members of Congress, and big-city mayors is finally over.

The end came not with a dramatic reveal or a formal ribbon-cutting, but with a largely bureaucratic and anticlimactic announcement that the Biden administration plans to share the wealth. ARPA-H will be housed in a hub-and-spoke model across three major metro areas: The D.C. suburbs; Cambridge, Mass.; and Dallas. Additional “spokes,” the agency announced Tuesday, will be spread across the country at 10 sites spanning from Florida to Alaska.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Grail spinoff by Illumina should end disastrous merger attempt

focus

WSS

Most antidepressants don't work on kids, teens, study finds

Has Bernie Sanders reached the limit of his pharma bullying effort?

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Warren pushes Witty on UnitedHealth's control over physicians

SEC charges former device maker CEO with $41 million fraud

Violet CEO on training clinicians to promote more inclusive care

hotspot

explore

focus

United colonoscopy coverage change 'may cost lives,' doctors say

The creative science of coining drug names

Dobbs anniversary: the lost opportunity of abortion as health care

Why health care costs have stayed mostly flat since 2010

As demand for Covid shots wanes, Moderna seeks its next success

What STAT readers think about the FDA and patient advocacy

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

SEC charges former device maker CEO with $41 million fraud

In age of alternative facts, a scholarly course on calling out crap

Is it ever OK for doctors to lie to their patients?

hotspot

Welsh Carson private equity firm escapes from FTC antitrust case

AltruBio raises $225 million to develop ulcerative colitis drug

Medicare Advantage beneficiaries sue Humana over algorithm use

Class action alleges UnitedHealth concealed DOJ probe

Has Bernie Sanders reached the limit of his pharma bullying effort?

Crowdfunding for medical bills sidesteps core problem, author says

entertainment

focus

focus

knowledge